S. Crettol, Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients, Pharmacogenetics and Genomics, vol.18, issue.4, pp.307-322, 2008.
DOI : 10.1097/FPC.0b013e3282f7046f

S. Bandur, J. Petrasek, P. Hribova, E. Novotna, I. Brabcova et al., Haplotypic Structure of ABCB1/MDR1 Gene Modifies the Risk of the Acute Allograft Rejection in Renal Transplant Recipients, Transplantation, vol.86, issue.9, pp.1206-1219, 2008.
DOI : 10.1097/TP.0b013e318187c4d1

G. Leschziner, T. Andrew, M. Pirmohamed, and M. Johnson, ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research, The Pharmacogenomics Journal, vol.14, issue.3, pp.154-79, 2007.
DOI : 10.1038/sj.tpj.6500413

D. Wang, A. Johnson, A. Papp, D. Kroetz, and W. Sadee, Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability, Pharmacogenetics and Genomics, vol.15, issue.10, pp.693-704, 2005.
DOI : 10.1097/01.fpc.0000178311.02878.83

C. Kimchi-sarfaty, A "Silent" Polymorphism in the MDR1 Gene Changes Substrate Specificity, Science, vol.315, issue.5811, pp.525-533, 2007.
DOI : 10.1126/science.1135308

F. Thiebaut, T. Tsuruo, H. Hamada, M. Gottesman, I. Pastan et al., Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues., Proceedings of the National Academy of Sciences, vol.84, issue.21, pp.7735-7743, 1987.
DOI : 10.1073/pnas.84.21.7735

I. Hauser, ABCB1 Genotype of the Donor but Not of the Recipient Is a Major Risk Factor for Cyclosporine-Related Nephrotoxicity after Renal Transplantation, Journal of the American Society of Nephrology, vol.16, issue.5, pp.1501-1512, 2005.
DOI : 10.1681/ASN.2004100882

P. Kuehl, Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression, Nature Genetics, vol.27, issue.4, pp.383-91, 2001.
DOI : 10.1038/86882

B. Haehner, Bimodal distribution of renal cytochrome P450 3A activity in humans, Mol Pharmacol, vol.50, pp.52-61, 1996.

Y. Dai, In vitro metabolism of cyclosporine A by human kidney CYP3A5, Biochemical Pharmacology, vol.68, issue.9, pp.1889-902, 2004.
DOI : 10.1016/j.bcp.2004.07.012

Y. Dai, EFFECT OF CYP3A5 POLYMORPHISM ON TACROLIMUS METABOLIC CLEARANCE IN VITRO, Drug Metabolism and Disposition, vol.34, issue.5, pp.836-883, 2006.
DOI : 10.1124/dmd.105.008680

D. Anglicheau, CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation, Clinical Pharmacology & Therapeutics, vol.75, issue.5, pp.422-455, 2004.
DOI : 10.1016/j.clpt.2004.01.009

M. Joy, V. Nickeleit, S. Hogan, B. Thompson, and W. Finn, Calcineurin Inhibitor???Induced Nephrotoxicity and Renal Expression of P-glycoprotein, Pharmacotherapy, vol.93, issue.5, pp.779-89, 2005.
DOI : 10.1006/bbrc.2001.5278

M. Naesens, E. Lerut, H. De-jonge, B. Van-damme, Y. Vanrenterghem et al., Donor Age and Renal P-Glycoprotein Expression Associate with Chronic Histological Damage in Renal Allografts, Journal of the American Society of Nephrology, vol.20, issue.11, pp.2468-80, 2009.
DOI : 10.1681/ASN.2009020192

D. Cattaneo, ABCB1 Genotypes Predict Cyclosporine-Related Adverse Events and Kidney Allograft Outcome, Journal of the American Society of Nephrology, vol.20, issue.6, pp.1404-1419, 2009.
DOI : 10.1681/ASN.2008080819

F. Cosio, IMPACT OF ACUTE REJECTION AND EARLY ALLOGRAFT FUNCTION ON RENAL ALLOGRAFT SURVIVAL, Transplantation, vol.63, issue.11, pp.1611-1616, 1997.
DOI : 10.1097/00007890-199706150-00013

A. Lindholm, S. Ohlman, D. Albrechtsen, G. Tufveson, H. Persson et al., The impact of acute rejection episodes on long-term graft function and outcome in 1347

A. Matas, K. Gillingham, W. Payne, and J. Najarian, THE IMPACT OF AN ACUTE REJECTION EPISODE ON LONG-TERM RENAL ALLOGRAFT SURVIVAL (t1/2)1,2, Transplantation, vol.57, issue.6, pp.857-866
DOI : 10.1097/00007890-199403270-00015

R. Kreutz, CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporine, The Pharmacogenomics Journal, vol.38, issue.6, pp.416-438, 2008.
DOI : 10.1016/S0009-9236(03)00168-1

M. Varagunam, M. Yaqoob, B. Dohler, and G. Opelz, C3 Polymorphisms and Allograft Outcome in Renal Transplantation, New England Journal of Medicine, vol.360, issue.9, pp.874-80, 2009.
DOI : 10.1056/NEJMoa0801861

S. Miller, D. Dykes, and H. Polesky, A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Research, vol.16, issue.3, pp.1215-1988
DOI : 10.1093/nar/16.3.1215

URL : http://doi.org/10.1093/nar/16.3.1215

D. Tregouet and L. Tiret, Cox proportional hazards survival regression in haplotype-based association analysis using the Stochastic-EM algorithm, European Journal of Human Genetics, vol.12, issue.11, pp.971-975, 2004.
DOI : 10.1038/sj.ejhg.5201238

M. Stephens and P. Donnelly, A Comparison of Bayesian Methods for Haplotype Reconstruction from Population Genotype Data, The American Journal of Human Genetics, vol.73, issue.5, pp.1162-1171, 2003.
DOI : 10.1086/379378